NPFFR2
Neuropeptide FF receptor 2
Also known as: GPR74, NPFF2, NPFF2_HUMAN, NPGPR
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y5X5
- Gene
- NPFFR2
- Ensembl
- ENSG00000056291
- Chromosome
- 4
- Canonical length
- 522 aa
- Protein class
- G-protein coupled receptors, Predicted membrane proteins
- Subcellular location
- Plasma membrane,Actin filaments
OverviewNCBI Gene
This gene encodes a member of a subfamily of G-protein-coupled neuropeptide receptors. This protein is activated by the neuropeptides A-18-amide (NPAF) and F-8-amide (NPFF) and may function in pain modulation and regulation of the opioid system. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2009]
Canonical amino-acid sequenceUniProt
522 residues, UniProt reviewed canonical sequence.
>Q9Y5X5|NPFFR2
1 MNSFFGTPAA SWCLLESDVS SAPDKEAGRE RRALSVQQRG GPAWSGSLEW SRQSAGDRRR
61 LGLSRQTAKS SWSRSRDRTC CCRRAWWILV PAADRARRER FIMNEKWDTN SSENWHPIWN
121 VNDTKHHLYS DINITYVNYY LHQPQVAAIF IISYFLIFFL CMMGNTVVCF IVMRNKHMHT
181 VTNLFILNLA ISDLLVGIFC MPITLLDNII AGWPFGNTMC KISGLVQGIS VAASVFTLVA
241 IAVDRFQCVV YPFKPKLTIK TAFVIIMIIW VLAITIMSPS AVMLHVQEEK YYRVRLNSQN
301 KTSPVYWCRE DWPNQEMRKI YTTVLFANIY LAPLSLIVIM YGRIGISLFR AAVPHTGRKN
361 QEQWHVVSRK KQKIIKMLLI VALLFILSWL PLWTLMMLSD YADLSPNELQ IINIYIYPFA
421 HWLAFGNSSV NPIIYGFFNE NFRRGFQEAF QLQLCQKRAK PMEAYALKAK SHVLINTSNQ
481 LVQESTFQNP HGETLLYRKS AEKPQQELVM EELKETTNSS EILocalizationUniProt · AlphaFold · HPA
Whether an antibody against NPFFR2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.45
- Highest tissue expression
- 6.7 nTPM
Expression across tissuesHPA
Tissue
- thymus: 6.7 nTPM
- seminal vesicle: 3 nTPM
- placenta: 1.5 nTPM
- epididymis: 0.8 nTPM
- retina: 0.7 nTPM
- amygdala: 0.4 nTPM
Single-cell type
- breast lactating cells: 380 nCPM
- early spermatids: 40 nCPM
- extravillous trophoblasts: 29 nCPM
- retinal horizontal cells: 28 nCPM
- other brain neurons: 28 nCPM
- syncytiotrophoblasts: 21 nCPM
Immune cell
- basophil: 0.3 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- hypothalamus: 3.6 nTPM
- amygdala: 3.2 nTPM
- basal ganglia: 3.2 nTPM
- cerebral cortex: 3 nTPM
- white matter: 2.1 nTPM
- medulla oblongata: 1.9 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.13
- gnomAD pLI
- 0
- gnomAD missense Z
- -1.17
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to hormone stimulus
- detection of abiotic stimulus
- G protein-coupled receptor signaling pathway
- neuropeptide signaling pathway
- regulation of MAPK cascade
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NPFFR2 as an antibody target. Whether an autoantibody or antibody against NPFFR2 could matter depends on whether native NPFFR2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NPFFR2 is annotated at the cell surface, where native NPFFR2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label NPFFR2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...